Altered Transcriptome Signature in Primary Human Myotubes Exposed to Inclusion Body Myositis Serum: A Pilot Case Comparison of Anti-cN1A Positive and Negative Sera

Inclusion body myositis (IBM) is a late-onset, treatment-resistant inflammatory myopathy. Approximately half of IBM patients develop autoantibodies against cytosolic <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><msup><mo>5</mo><mo>′</mo></msup></semant...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Nataliya Slater, Abha Chopra, Ramesh Ram, Abbie Adams, Frank L. Mastaglia, Merrilee Needham, Jerome D. Coudert
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2025-11-01
Rangatū:	Muscles
Ngā marau:	inclusionbody myositis cytosolic 5′-nucleotidase 1A NT5C1A anti-cN1A autoantibodies primary human myotubes
Urunga tuihono:	https://www.mdpi.com/2813-0413/4/4/53
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!